James Popp

Dr. Popp is widely recognized for his research and leadership contributions in toxicology and toxicological pathology. He received a Doctor of Veterinary Medicine degree followed by a Ph.D. and pathology residency training leading to certification as a Diplomate of the American College of Veterinary Pathology. Following Post Doctoral training in chemical carcinogenesis, he served on the faculty of the University of Florida before joining the Chemical Industry Institute of Toxicology (CIIT) shortly after the Institute was founded.

Over the ensuing 15 years Dr. Popp developed and directed a productive research program in hepatocarcinogenesis. During part of his tenure at CIIT he served as a Department Head and Vice President of the Institute. He has held several Vice President positions overseeing toxicology programs in the pharmaceutical industry for 11 years before founding Stratoxon LLC, a toxicology consulting organization.

Dr. Popp has served in the leadership of several professional societies including the positions of President of the Society of Toxicologic Pathology, President of The Academy of Toxicological Sciences and President of The Society of Toxicology.

Dr. Popp is a frequent contributor to governmental toxicology efforts including participation in the Strategic Planning activities for both the National Toxicology Program (NTP) and the National Institutes of Environmental Health Sciences (NIEHS). He has completed a 3 year term on the NTP Board of Scientific Counselors and the Report on Carcinogens subcommittee.

Dr. Popp has also served as Chair of 2 NTP special Workshops and is currently serving as Chair of the Board of Scientific Advisors for the FDA National Center for Toxicological Research.